Challenges and Opportunities in Managing Relapsed/Refractory Multiple Myeloma: Expert Perspectives

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Faculty

María-Victoria Mateos, MD, PhD

Professor of Medicine
University of Salamanca
Salamanca, Spain

Disclosures

Disclosure: Maria-Victoria Mateos, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie, Inc.; Amgen, Inc.; Bristol Myers Squibb Company; Celgene Corporation; GlaxoSmithKline; Janssen; Oncopeptides AB; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Roche; Sanofi; Seagen Inc., formerly Seattle Genetics, Inc.; Takeda
Speaker or member of speakers bureau for: Bristol Myers Squibb Company; Celgene Corporation; Janssen
Research funding from: Amgen, Inc.; Bristol Myers Squibb Company; Celgene Corporation; GlaxoSmithKline

Nina Shah, MD

Nina Shah, MD

Associate Professor of MedicineUniversity of California San FranciscoSan Francisco, California, United States

Disclosures

Disclosure: Nina Shah, MD, has the following relevant financial relationships:
Consultant or advisor for: Amgen, Inc.; CareDx; CSL Behring; GlaxoSmithKline; Indapta Therapeutics, Inc.; Karyopharm; Kite Pharma, Inc.; Oncopeptides AB; Sanofi
Research funding from: bluebird bio, Inc.; Bristol Myers Squibb Company; Celgene Corporation; Janssen; Nektar Therapeutics; Poseida Therapeutics; Precision Biosciences; Sutro Biopharma, Inc.; TeneoBio

Editors

Sanneke Koekkoek

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Sanneke Koekkoek has no relevant financial relationships.

Chii Shyang Fong, PhD

Scientific Content Manager, WebMD Global, LLC

Disclosures

Disclosure: Chii Shyang Fong, PhD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance

Disclosures

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

processing....

Deutscher Expertenkommentar

Dieser Kommentar ist Teil einer größeren Fortbildungsmaßnahme. Kehren Sie für den Zugriff auf alle zugehörigen Fortbildungsinhalte nach Ihrer Teilnahme bitte zurück zu " Challenges and Opportunities in Managing Relapsed/Refractory Multiple Myeloma: Expert Perspectives ."

« Return to: Challenges and Opportunities in Managing Relapsed/Refractory Multiple Myeloma: Expert Perspectives